Symansis (SYMA001)

Symansis is a company set up by a group of leading cancer research scientists from the UK, USA and New Zealand. Their expert knowledge has been encapsulated in the growing product range. To help turn their ideas into reality they have brought together an operational team with both international and commercially-based experience. Every senior member of the team has a track record of success in other biotech companies in Europe, the USA or Australasia and all are aware of the needs for quality and design to meet world standards. The company works closely with academic collaborators in the UK, Hong Kong, Australia and the USA giving it a very interesting continuing pipeline of new product ideas. Symansis uses its New Zealand base to produce its high quality raw materials in the disease-free environment that results from its geography, and yet is still within easy reach by air of all markets.

NEW MULTI-KINASE ELISA ARRAY